Stockscreener 앱 받기
1.76
4.14%
0.07
시간 외 거래:
1.76
전일 마감가:
$1.69
열려 있는:
$1.75
하루 거래량:
46,331
Relative Volume:
1.52
시가총액:
$28.78M
수익:
$49.70M
순이익/손실:
$-10.86M
주가수익비율:
-3.6667
EPS:
-0.48
순현금흐름:
$-5.79M
1주 성능:
+23.08%
1개월 성능:
+7.32%
6개월 성능:
-33.83%
1년 성능:
-11.11%
1일 변동 폭
$1.685
$1.80
1주일 범위
$1.36
$1.94
52주 변동 폭
$1.2717
$3.65
Iridex Corp Stock (IRIX) Company Profile
명칭
Iridex Corp
전화
(650) 940-4700
주소
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
IRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| IRIX | 1.76 | 28.78M | 49.70M | -10.86M | -5.79M | -0.48 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-11-03 | 재개 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | ROTH Capital | Buy |
| 2016-01-26 | 개시 | Singular Research | Buy |
| 2007-01-03 | 개시 | First Albany | Buy |
Iridex Corp 주식(IRIX)의 최신 뉴스
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - Insider Monkey
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Iridex Q3 Revenue Falls 10% YoY, Aims for Q4 EBITDA Breakeven Amid Strategic Review | IRIX Stock News - StockTitan
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
IRIX Stock Sees Significant Drop Amid Market Fluctuation - GuruFocus.com
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 9.9% in October - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Ophthalmic Photocoagulator Market to Witness Huge Growth by 2032 |Alcon, NIDEK, IRIDEX, Lumenis Be - openPR
IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com - Defense World
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseasesTechnavio - The Malaysian Reserve
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
IRIX stock touches 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa
IRIX stock touches 52-week low at $1.62 amid market challenges - Investing.com Australia
Iridex names Patrick Mercer as new CEO to drive strategic review - Investing.com
Iridex Appoints Patrick Mercer as Chief Executive Officer - StockTitan
Medical Laser Market Size, Share, Growth and Industry Trends – news - North America Agile Program ...
Medical Laser Technology Market Size, Share, Trends & Forecast - Third Eye News
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Global Diabetes Associated Ophthalmic Treatment Market Size To Exceed USD 56.43 Billion By 2033 l CAGR Of 6.61% - India Shorts
Iridex (NASDAQ:IRIX) Stock Quotes, Forecast and News Summary - Benzinga
Iridex Frustrates, But Expect A Transaction By Year-End (NASDAQ:IRIX) - Seeking Alpha
Iridex finds accounting error, Q1 loss to widen by 1 cent/shr - Reuters
IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Call Transcript - Insider Monkey
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Earnings call: IRIDEX sees growth in Q2 with strategic review underway - Investing.com Canada
Iridex revenue drops to USD 12.6M in Q2 2024 - Medical Buyer
IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript - Seeking Alpha
Iridex: Q2 Earnings Snapshot - Houston Chronicle
Iridex Reports Second Quarter 2024 Financial Results - Yahoo Finance
Iridex announces convertible note financing - Medical Buyer
Iridex secures $3.5 million in private placement financing - Investing.com
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
Iridex Announces Convertible Note Financing - Yahoo Finance
IRIDEX (IRIX) Set to Announce Earnings on Thursday - Defense World
Energy-Based Aesthetic Devices Market size is set to grow by USD 2.13 billion from 2024-2028, Increasing demand for aesthetic procedures boost the market, Technavio - The Malaysian Reserve
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 - StockTitan
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
ENT Laser Devices Market to Witness an Outstanding Growth by 2032 - openPR
IRIDEX Co. (NASDAQ:IRIX) Short Interest Update - Defense World
Energy-Based Aesthetic Devices Market size is set to grow by USD 2.13 billion from 2024-2028, Increasing demand for aesthetic procedures to boost the market growth, Technavio - The Malaysian Reserve
Energy-Based Aesthetic Devices Market Size Is Set To Grow By USD 2.13 Billion From 2024-2028, Increasing Demand For Aesthetic Procedures To Boost The ... - MENAFN.COM
Retinal Laser Photocoagulation Market Size Report, 2030 - Grand View Research
Iridex Corp (IRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):